Clinical Trial Update: Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel in combination with UFT and leucovorin for advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Leucovorin (folinic acid)
• Taxol (paclitaxel) (paclitaxel)
• UFT (tegafur-uracil)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED